SMTL ID : 6wpt.1

Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state)

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY 3.70 Å
Oligo State
hetero-3-2-2-mer
Ligands
10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- NAG- BMA- MAN- MAN- FUC: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
35 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Pinto, D. et al., Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature (2020)
Release Date
2020-05-27
Peptides
spike glycoprotein: ABC
S309 neutralizing antibody heavy chain: DF
S309 neutralizing antibody light chain: EG
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
H
F
D
E
L
G
E

spike glycoprotein

S309 neutralizing antibody heavy chain

Toggle Identical (DF)

S309 neutralizing antibody light chain

Related Entries With Identical Sequence

6vxx.1 | 6wps.1 | 7jv2.1 | 7jv4.1 | 7jv6.1 | 7jva.1 | 7jvc.1 | 7jw0.1 | 7k43.1 | 7mtc.1 | 7mtd.1